Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 3,474 | 3,763 | 3,773 | 4,124 | 4,418 |
| Cost of Goods | 699 | 454 | 634 | 595 | 701 |
| Gross Profit | 2,774 | 3,309 | 3,140 | 3,529 | 3,717 |
| Operating Expenses | 37,835 | 36,785 | 28,490 | 25,805 | 19,250 |
| Operating Income | -34,361 | -33,022 | -24,716 | -21,681 | -14,832 |
| Interest Expense | 2,053 | 531 | 0 | 0 | 0 |
| Other Income | 809 | 334 | 315 | 253 | 167 |
| Pre-tax Income | -35,605 | -33,219 | -24,402 | -21,427 | -14,665 |
| Net Income Continuous | -35,605 | -33,219 | -24,402 | -21,427 | -14,665 |
| Net Income | $-35,605 | $-33,219 | $-24,402 | $-21,427 | $-14,665 |
| EPS Basic Total Ops | -8.00 | -7.50 | -5.50 | -4.50 | -3.50 |
| EPS Basic Continuous Ops | -7.80 | -7.67 | -5.63 | -5.00 | -3.53 |
| EPS Diluted Total Ops | -8.00 | -7.50 | -5.50 | -4.50 | -3.50 |
| EPS Diluted Continuous Ops | -7.80 | -7.67 | -5.63 | -5.00 | -3.53 |
| EBITDA(a) | $-34,168 | $-32,926 | $-24,657 | $-21,625 | $-14,778 |